Treatment of acute lymphoblastic leukemia.
Pui
Ching-Hon
CH
Department of Hematology and Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. ching-hon.pui@stjude.org
Evans
William E
WE
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use; D020869:Gene Expression Profiling; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction / Q000379:methods; D018570:Risk Assessment; D033581:Stem Cell Transplantation; D016019:Survival Analysis
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D001215:Asparaginase; D008727:Methotrexate